Singulex Clinical Laboratory

Singulex views quality as one of the most essential elements of our company. We are committed to excellence and we have implemented policies, processes and procedures to ensure that quality standards are achieved and exceeded. Quality improvement processes recommended by legislative agencies and professional organizations are used at Singulex Clinical Laboratory to maintain and improve the standard of patient care and to address unique client needs. Through constant monitoring and a focus upon continual improvement, Singulex Clinical Laboratory ensures that clients are satisfied with the service they receive.

Click the links below to read more about each topic:

Compliance Statement.

The Singulex Clinical Laboratory has developed Sgx HD™ tests and determined their performance characteristics. The U.S. Food and Drug Administration (FDA) has not approved or cleared these tests; however, FDA clearance or approval is not currently required for clinical use. Test results are not intended as the sole means for clinical diagnosis or patient management decisions.

Health Insurance Portability and Accountability Act (HIPAA) and Singulex Clinical Laboratory.

Singulex Clinical Laboratory is committed to complying with the Heath Insurance Portability and Accountability Act (HIPAA) regulations. Singulex Clinical Laboratory has implemented policies, processes and procedures designed to ensure compliance with these standards.

Compliance to the standards are monitored continuously and audited for effectiveness. Singulex Clinical Laboratory complies with the Security standards by insuring that its systems, policies and procedures meet or exceed all required and addressable implementation specifications. Electronic and physical access to systems and information is limited to only authorized individuals.

Click here to download a copy of Notice of Privacy Practices.